Tegolasen tablets are a drug developed by Luoxin Pharmaceuticals for the treatment of reflux esophagitis.
On April 13, 2022, Luoxin Pharmaceuticals announced that its subsidiary Shandong Luoxin received the “Drug Registration Certificate” for Tegolasen tablets for the treatment of reflux esophagitis approved and issued by the National Medical Products Administration. [1]
Let us work together to protect precious health